Brain Code, Inc to revolutionize the detection of traumatic brain injury
20 October 2023
/
BrainDTech and Great Product Ventures announce BrainCode, a US Joint Venture with the products and science for providing early and precise diagnostics for precision medicine.
We are excited to announce that BrainDTech, one of the promising entities incubated and affiliated by Bio4Dreams, has established a joint venture with Great Product Ventures to found Brain Code Inc. This strategic collaboration aims to revolutionize the early diagnosis of traumatic brain injuries through the use of non-invasive biomarkers.
Brain Code
The JV, headquartered in Cambridge MA with a CLIA-certified lab facility in Dallas, TX, will deliver fast and reliable tests to monitor brain inflammation as it develops in complex brain diseases such as Traumatic Brain Injury, brain inflammation and other critical neurodegenerative diseases in order to support crucial and time-sensitive decisions regarding detection and therapy.
The company, endowed by BrainDTech’s proprietary microfluidic platform MicroCATCH and accelerated by one of the most innovative venture development firms in the U.S. and Europe, will also take advantage of the industrial expertise of Brian Meshkin, Board Member and Partner of the Company is an Award-Winning Technology Entrepreneur & Executive who has led some of the fastest growing technology companies in North America in the field of precision medicine.
“The signing of this JV represents for BrainDTech an important milestone in its global expansion strategy as we strive to deliver a revolution in precision medicine biomarker development for complex disease identification and monitoring.”
Fabio Bianco, CEO of BrainDTech
At least 2.8 million Americans sustain traumatic brain injuries in the United States every year. Traumatic Brain Injury can not only lead to lifelong damage for the individual effected but can mask itself during the first 48 hours. Most TBI victims “appear” to recover within 48 hours using standard testing, only to suffer death or debilitating injury after the 48-hour period. BrainCode solve this problem in 20 minutes.
“Doing well by doing good has always been our motto […] The technology developed by BrainDTech over the last many years is going to be very impactful in people’s lives. We see MicroCATCH having a huge benefit in the early diagnosis of Traumatic Brain Injury in Athletes, our Military, and others. […] Every First Responder should have a MicroCATCH onboard.”
Jonathan Ramaci, CEO of both Great Product and Brain Code
MicroCATCH
The MicroCATCH Platform is a portable, IoT enabled device capable of testing a various, noninvasive body fluids and precisely detecting certain biomarkers within minutes. These biomarkers have undergone years of scientific rigor and can be used to determine TBI, Dementia and other diseases of the brain.
Congratulations to BrainDTech and everyone involved in this extraordinary initiative. We will continue to support BrainDTech with dedication, as well as all the other entities within our network, in the development of meaningful innovative solutions in the field of Life Sciences.
News
Ultimi aggiornamenti
17 May 24
Bio4Dreams entra nel network ELITE
Bio4Dreams è stata selezionata per entrare in ELITE, network di Euronext nato per supportare la crescita sostenibile delle PMI.
14 May 24
Un premio dedicato a Ennio Ongini per la finale del BioInvestIT
Finale BioInvestIT, forum sulla bioeconomia circolare: Bio4Dreams mette in palio un premio in onore di Ennio Ongini, amico e scienziato.
7 May 24
Insieme a Circular Change per promuovere l’economia circolare
Nuova partnership italo-slovena per rafforzare il network internazionale e promuovere innovazione e sostenibilità attraverso l’economia circolare.